← Open Payments lookup

ADEWALE OYEMADE: Open Payments

NPI 1801054366 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,026 in 46 payments from 13 companies in 2025. Trend: 2023 $1,138 · 2024 $876 · 2025 $1,026

Food & beverage: $987Education: $39
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.6$153
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$139
Corium, LLC6$115
Supernus Pharmaceuticals, Inc.3$112
Takeda Pharmaceuticals U.S.A., Inc.5$110
Noven Therapeutics, LLC5$93
Axsome Therapeutics, Inc.4$92
Tris Pharma Inc4$78
Lundbeck LLC1$39
Vertical Pharmaceuticals, LLC2$33

Products named: REXULTI, CAPLYTA, Azstarys, Qelbree, TRINTELLIX, Xelstrym, Auvelity, Onyda XR.

Industry payments across LA — which companies pay providers there.